GB0520316D0 - Treatment of neurodegenerative and psychiatric diseases - Google Patents
Treatment of neurodegenerative and psychiatric diseasesInfo
- Publication number
- GB0520316D0 GB0520316D0 GB0520316A GB0520316A GB0520316D0 GB 0520316 D0 GB0520316 D0 GB 0520316D0 GB 0520316 A GB0520316 A GB 0520316A GB 0520316 A GB0520316 A GB 0520316A GB 0520316 D0 GB0520316 D0 GB 0520316D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- neurodegenerative
- treatment
- psychiatric diseases
- psychiatric
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 230000000626 neurodegenerative effect Effects 0.000 title 1
- 208000020016 psychiatric disease Diseases 0.000 title 1
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0520316A GB0520316D0 (en) | 2005-10-06 | 2005-10-06 | Treatment of neurodegenerative and psychiatric diseases |
JP2008534088A JP2009511462A (en) | 2005-10-06 | 2006-10-05 | Use of condensed pyrrole carboxylic acids to treat neurodegeneration and psychiatric disorders as D-amino acid oxidase inhibitors |
PCT/GB2006/050317 WO2007039773A1 (en) | 2005-10-06 | 2006-10-05 | Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors |
CA002624795A CA2624795A1 (en) | 2005-10-06 | 2006-10-05 | Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors |
US11/992,913 US20090306169A1 (en) | 2005-10-06 | 2006-10-05 | Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors |
AU2006298563A AU2006298563A1 (en) | 2005-10-06 | 2006-10-05 | Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as D-amino acid oxidase inhibitors |
EP06779660A EP1942885A1 (en) | 2005-10-06 | 2006-10-05 | Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0520316A GB0520316D0 (en) | 2005-10-06 | 2005-10-06 | Treatment of neurodegenerative and psychiatric diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0520316D0 true GB0520316D0 (en) | 2005-11-16 |
Family
ID=35429902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0520316A Ceased GB0520316D0 (en) | 2005-10-06 | 2005-10-06 | Treatment of neurodegenerative and psychiatric diseases |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0520316D0 (en) |
-
2005
- 2005-10-06 GB GB0520316A patent/GB0520316D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20150175T1 (en) | Means and methods for the treatment of tumorous diseases | |
EP1968607A4 (en) | Treatment of cancer and other diseases | |
EP1861126A4 (en) | Treatment of protein degradation disorders | |
EP2004204A4 (en) | Treatment of neurodegenerative diseases | |
ZA200800907B (en) | Treatment of cancer | |
GB0603181D0 (en) | Treatment of neurodegenerative and psychiatric diseases | |
GB2415378B (en) | Treatment of neurodegenerative conditions | |
EP1957064A4 (en) | Treatment of qt interval prolongation and diseases associated therewith | |
GB2422373B (en) | Treatment of neurodegenerative conditions | |
EP1962869A4 (en) | Treatment of respiratory diseases | |
GB0610183D0 (en) | Treatment of neurodegenerative diseases | |
GB0523961D0 (en) | The treatment of ophthalmic diseases | |
ZA200806095B (en) | Means and methods for the treatment of tumorous diseases | |
ZA200805108B (en) | Treatment of neurodegenerative disorders | |
ZA200802270B (en) | Treatment of neurodegenerative disorders | |
GB0300783D0 (en) | Treatment of neurodegenerative conditions | |
EP1951282A4 (en) | Treatment of hypersensitivity | |
GB0520067D0 (en) | Treatment of cancer | |
GB0519274D0 (en) | The treatment of neurodegenerative diseases | |
GB0523964D0 (en) | The treatment of ophthalmic diseases | |
GB0520316D0 (en) | Treatment of neurodegenerative and psychiatric diseases | |
EP1846013A4 (en) | Treatment of skin diseases | |
GB0602783D0 (en) | Treatment Of Neurodegenerative And Psychiatric Diseases | |
GB0410846D0 (en) | Treatment of neurodegenerative conditions | |
GB2442164B (en) | Treatment of neurodegenerative conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |